Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

The Current Regulatory Focus on Options Dating Practices

Related Content

SEC Staff Publishes Revisions to S-K Item 103 Legal Proceedings C&DIs

How to Write an Effective Public Benefit Report

Federal Reserve Removes References to Reputation and Reputational Risk in Its Supervisory Materials

SEC Withdraws Proposed Amendments to Shareholder Proposal Rule

OCC Reaffirms Federal Preemption Regulations

SEC Investor Advisory Committee Considers Shareholder Engagement and Non-GAAP Disclosures

CFPB Issues Final Rule Removing Requirement for State Officials to Notify CFPB of State Actions Enforcing the CFPA

Healthcare M&A Poised for a Rebound in 2025

Sanofi Completes Acquisition of Blueprint Medicines

Synopsys Completes Acquisition of Ansys

Goodwin Is Number One Law Firm for Global M&A for H1 2025

Olo to be Taken Private by Thoma Bravo for Approximately $2.0 Billion

Goodwin Represents Superhuman in Agreement to Be Acquired by Grammarly

Goodwin Advised Landmark Bio in Acquisition by Artis BioSolutions to Expand Manufacturing and Commercialization of Advanced Therapies

SpringWorks Therapeutics Completes Acquisition by Merck KGaA, Darmstadt, Germany to Accelerate Sustainable Growth for $3.9 Billion

Fixing a Broken Record (PitchBook)

Technology

Life Sciences

Mergers & Acquisitions

Capital Markets

Securities Litigation & SEC Enforcement

Data, Privacy & Cybersecurity

Strategic Technology Transactions and Licensing

Patent Prosecution & Counseling

Patent Litigation

Trademarks

Life Sciences Patent Prosecution & Counseling